Perinatal Outcome following the Suspension of Intrapartum Oxygen Treatment.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
17 Apr 2023
Historique:
pubmed: 10 3 2023
medline: 10 3 2023
entrez: 9 3 2023
Statut: aheadofprint

Résumé

 This study aimed to evaluate whether the suspension of intrapartum maternal oxygen supplementation for nonreassuring fetal heart rate is associated with adverse perinatal outcomes.  A retrospective cohort study, including all individuals that underwent labor in a single tertiary medical center. On April 16, 2020, the routine use of intrapartum oxygen for category II and III fetal heart rate tracings was suspended. The study group included individuals with singleton pregnancies that underwent labor during the 7 months between April 16, 2020, and November 14, 2020. The control group included individuals that underwent labor during the 7 months before April 16, 2020. Exclusion criteria included elective cesarean section, multifetal pregnancy, fetal death, and maternal oxygen saturation <95% during delivery. The primary outcome was defined as the rate of composite neonatal outcome, consisting of arterial cord pH <7.1, mechanical ventilation, respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage grade 3/4, and neonatal death. The secondary outcome was the rate of cesarean and operative delivery.  The study group included 4,932 individuals, compared with 4,906 individuals in the control group. The suspension of intrapartum oxygen treatment was associated with a significant increase in the rate of composite neonatal outcome (187 [3.8%] vs. 120 [2.4%],  Suspension of intrapartum oxygen treatment for nonreassuring fetal heart rate was associated with higher rates of adverse neonatal outcomes and urgent cesarean section due to fetal heart rate. · The available data on intrapartum maternal oxygen supplementation are equivocal.. · Suspension of maternal oxygen for nonreassuring fetal heart rate during labor was associated with adverse neonatal outcomes.. · Oxygen treatment might still be important and relevant during labor..

Identifiants

pubmed: 36894155
doi: 10.1055/a-2051-4047
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Yossi Bart (Y)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Raanan Meyer (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Orit Moran (O)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Abraham Tsur (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Eran Kassif (E)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Aya Mohr-Sasson (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Emily Hamilton (E)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Eyal Sivan (E)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Yoav Yinon (Y)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Shali Mazaki-Tovi (S)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Rakefet Yoeli (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Classifications MeSH